• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18320
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Hyperglycemia (1905); Vomiting (2144); Malaise (2359); Elevated ketones/Diabetic Ketoacidosis (2364)
Date of Event 06/29/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient was transported to the emergency room by ambulance and subsequently admitted to southampton general hospital with diabetic ketoacidosis (dka) on (b)(6) 2025.While wearing the pod between 37 and 48 hours, the patient¿s blood glucose levels reportedly rose to the high 20 mmol/l range (around 360 mg/dl).The patient attempted multiple correction boluses with no effect on glucose levels.The patient initially believed the symptoms were related to food poisoning, but as the condition worsened¿marked by hyperglycemia, vomiting, and lethargy¿medical services were contacted.The patient was treated with intravenous fluids and an insulin drip.The pod was removed and discarded at the hospital.The patient was discharged the following day, (b)(6) 2025, after approximately 16 hours of hospitalization.
 
Additional Manufacturer Narrative
According to the complainant the device will not be available for investigation because it was discarded.We are unable to determine if any product condition could have contributed to the reported hospitalization and diabetic ketoacidosis.No lot release records were reviewed, as the product lot number was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH INSULIN MANAGEMENT SYSTEM
Common Device Name
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
derek heyl
100 nagog park
acton, MA 01720
9786007000
MDR Report Key24738514
Report Number3014585508-2026-16893
Device Sequence Number8843390
Product Code LZG
UDI-Device Identifier20385082000020
UDI-Public(01)20385082000020
Combination Product (Y/N)N
PMA/510(K) Number
K211575
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Consumer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number18320
Device Catalogue NumberBLE-I1-529
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/13/2026
Initial Report FDA Received Date03/31/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age39 YR
Patient SexFemale
-
-